KIR gene frequencies as detected by PCR-SSP for all patients and recipients and a control panel of healthy blood donors
. | Lymphoid disease, %* . | . | Myeloid leukemia, %† . | . | . | ||
---|---|---|---|---|---|---|---|
KIR . | Donor . | Recipient . | Donor . | Recipient . | Controls, %‡ . | ||
2DL1 | 94 | 97 | 91 | 91 | 93 | ||
2DL2 | 42 | 43 | 50 | 49 | 52 | ||
2DL3 | 92 | 96 | 90 | 91 | 93 | ||
2DL4 | 100 | 100 | 100 | 100 | 100 | ||
2DL5 | 43 | 43 | 41 | 43 | 40 | ||
3DL1 | 93 | 93 | 91 | 90 | 94 | ||
3DL2 | 100 | 100 | 100 | 100 | 100 | ||
2DS1 | 39 | 39 | 38 | 37 | 45 | ||
2DS2 | 42 | 42 | 51 | 52 | 55 | ||
2DS3 | 27 | 23 | 25 | 26 | 25 | ||
2DS4 | 91 | 91 | 90 | 82 | 87 | ||
2DS5 | 31 | 27 | 28 | 27 | 33 | ||
3DS1 | 32 | 34 | 28 | 30 | 42 |
. | Lymphoid disease, %* . | . | Myeloid leukemia, %† . | . | . | ||
---|---|---|---|---|---|---|---|
KIR . | Donor . | Recipient . | Donor . | Recipient . | Controls, %‡ . | ||
2DL1 | 94 | 97 | 91 | 91 | 93 | ||
2DL2 | 42 | 43 | 50 | 49 | 52 | ||
2DL3 | 92 | 96 | 90 | 91 | 93 | ||
2DL4 | 100 | 100 | 100 | 100 | 100 | ||
2DL5 | 43 | 43 | 41 | 43 | 40 | ||
3DL1 | 93 | 93 | 91 | 90 | 94 | ||
3DL2 | 100 | 100 | 100 | 100 | 100 | ||
2DS1 | 39 | 39 | 38 | 37 | 45 | ||
2DS2 | 42 | 42 | 51 | 52 | 55 | ||
2DS3 | 27 | 23 | 25 | 26 | 25 | ||
2DS4 | 91 | 91 | 90 | 82 | 87 | ||
2DS5 | 31 | 27 | 28 | 27 | 33 | ||
3DS1 | 32 | 34 | 28 | 30 | 42 |